Tag: stem cell therapy market trends

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Are the Key Milestones in the Stem Cell Therapy Market’s Growth Trajectory From 2025 To 2034?#_x000D_

In recent times, there has been a swift expansion in the market size of stem cell therapy. It is projected to escalate from a worth of $7.86 billion in 2024 to $9.26 billion in 2025, with a compound annual growth rate (CAGR) of 17.7%. The historical growth surge can be credited to factors like the increasing incidence of chronic illnesses, greater funding from government and private bodies, swift advancement in emerging markets, a rise in investments in cell and gene therapies, an upsurge in healthcare spending, along with an increase in pharmaceutical research and development expenditures._x000D_

_x000D_

The market for stem cell therapy is projected to experience swift expansion over the coming years, reaching $14.6 billion by 2029 with a compound annual growth rate (CAGR) of 12.1%. Key drivers of this growth over the forecast period include enhanced government backing, a swiftly rising elderly population, increased funding for research and development, and escalating healthcare expenditure. Noteworthy trends during the forecast period involve an emphasis on meticulous tracking of progress in mesenchymal stem cell therapy to leverage field innovation, collaboration and acquisition between market participants to propel product innovation and revenue, an important investment consideration for companies would be the development of ipsc-derived nk cells, market operators in stem cell therapy should focus on advancing stem cell therapy particularly for cancer to have an edge over somatic cell competitors, and AI utilisation should be considered by companies in the stem cell therapy market to improve product quality, ensure safety, and enhance manufacturing productivity._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the Stem Cell Therapy Market?#_x000D_

The increase in chronic diseases has fueled the expansion of the stem cell therapy market. The prevalence of chronic diseases among individuals can be attributed to extended working hours, lack of physical exercise, and poor eating and drinking habits, all of which enhance the demand for stem cell therapy. A United Nations report predicts that by 2030, chronic diseases will account for 70% of total global death rates. The anticipated worldwide burden of these diseases is set to reach approximately 60%. Thus, the escalating occurrence of chronic diseases is forecasted to propel the growth of the stem cell therapy market._x000D_

_x000D_

#How Is the Stem Cell Therapy Market Segmented?#_x000D_

The stem cell therapy market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy_x000D_

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells_x000D_

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others_x000D_

4) By End-Users: Hospitals And Clinics, Research Centers, Others._x000D_

_x000D_

Subsegments:_x000D_

1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells _x000D_

2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3399&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Stem Cell Therapy Market Growth?#_x000D_

North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Key Trends Are Shaping the Future of the Stem Cell Therapy Market?#_x000D_

Strategic partnerships are becoming increasingly popular amongst businesses in the stem cell therapy market. This type of partnership is characterized by mutually beneficial agreements, typically between two companies not in direct competition. In May 2022, an illustration of such a partnership was seen when SQZ Biotechnologies, a company based in the US, collaborated with STEMCELL Technologies Inc., based in Canada. The joint effort is focused on developing a microfluidic intracellular delivery system for research use only (RUO), which is based on the Cell Squeeze technology by SQZ. This enterprise aims to give the scientific community enhanced abilities to engineer cells for preclinical research. Integral findings surrounding the efficiency of the RUO system in delivering cargoes to primary immune cell types will be presented by both companies, alongside breakthroughs in hematopoietic stem cell engineering via mRNA and CRISPR/Cas9._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report_x000D_

_x000D_

#How Is the Stem Cell Therapy Market Defined and What Are Its Core Parameters?#_x000D_

Stem cell therapy refers to a form of regenerative medicine that uses stem cells or their byproducts to stimulate the body’s natural repair process in damaged, malfunctioning, or wounded tissue. It is the next step in the transplantation of organs, replacing donor organs—which are scarce—with cells._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3399_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Stem Cell Therapy Market Grown from 2024 to 2025?

In recent times, the market size of stem cell therapy has experienced quick expansion. The size is forecasted to increase from $7.86 billion in 2024 to $9.26 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 17.7%. This notable growth during the historical period is due to several key elements, such as the escalating prevalence of chronic illnesses, intensifying funding support from government and private entities, the rapid growth of upcoming markets, rising investments in cell and gene treatments, a boost in healthcare spends, and an augment in expenditure on pharmaceutical R&D.

What Growth Rate Is Anticipated for the Stem Cell Therapy Market in the Coming Years?

The market for stem cell therapy is predicted to experience a rapid surge in size in the coming years, projected to reach $14.6 billion by 2029, with a compound annual growth rate (CAGR) of 12.1%. This projected growth within the forecast period can be tied to a number of contributing factors, including burgeoning support from the government, a swift increase in the elderly population, a uptick in research and development expenditures, and a rise in healthcare spending. The forecast period will likely see several key trends; an emphasis on closely observing advancements in mesenchymal stem cell therapy with the aim of reaping benefits from field innovations, collaborations and acquisition of other firms by market players to bolster product innovation and increase revenue, companies should ponder on investing in developing ipsc-derived nk cells for patient treatment, a focus on stem cell therapy development by firms operating in this market specifically for cancer treatment as a way to secure a competitive edge against somatic cell rivals, and the implementation of artificial intelligence by companies in the stem cell therapy market to enhance product quality, safety and manufacturing efficiency.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

Who Are the Leading Companies in the Stem Cell Therapy Market?

Major companies operating in the stem cell therapy market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mabion, Pure Biologics, Oncoarendi Therapeutics, Celon Pharma, Becton Dickinson And Company, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi S.A.

What Are the Key Drivers of the Stem Cell Therapy Market?

The increasing occurrence of chronic illnesses is aiding the expansion of the stem cell therapy market. Extended work hours, lack of physical exercise, and unhealthy consumption habits are the factors contributing to the prevalence of chronic diseases, thus enhancing the need for stem cell therapy. A United Nations article predicts that by 2030, chronic diseases will account for 70% of all deaths globally. The global implication of chronic diseases is predicted to reach approximately 60%. Thus, the increasing prevalence of chronic illnesses is anticipated to propel the growth of the stem cell therapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3399&type=smp

What Are the Key Market Segments in the Stem Cell Therapy Industry?

The stem cell therapy market covered in this report is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others

4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:

1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells

2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

What Are the Latest Trends in the Stem Cell Therapy Market?

Strategic partnerships are gaining momentum among firms within the stem cell therapy market. This type of collaboration, often non-competitive, is mutually beneficial to both companies involved. As an example, SQZ Biotechnologies, a biotech firm from the United States, formed a strategic alliance with Canada’s STEMCELL Technologies Inc. in May 2022. Together, they aim to develop and bring to market a research-only microfluidic intracellular delivery system based on SQZ’s proprietary Cell Squeeze technology. This will give the life sciences sector enhanced cell engineering potential for use in preclinical studies. The two businesses will publish important data revealing the RUO system’s potential to deliver cargoes efficiently to primary immune cells and highlight advancements in cell engineering using mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

What Are the Key Regional Markets in the Stem Cell Therapy Industry?

North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3399

This Report Delivers Insight On:

1. How big is the stem cell therapy market, and how is it changing globally?

2. Who are the major companies in the stem cell therapy market, and how are they performing?

3. What are the key opportunities and risks in the stem cell therapy market right now?

4. Which products or customer segments are growing the most in the stem cell therapy market?

5. What factors are helping or slowing down the growth of the stem cell therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the stem cell therapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Key Milestones in the Stem Cell Therapy Market’s Growth Trajectory From 2025 To 2034?

The market size for stem cell therapy has witnessed a swift expansion in recent years. It is projected to escalate from $7.86 billion in 2024 to $9.26 billion in 2025, indicating a compound annual growth rate (CAGR) of 17.7%. The significant growth seen in the earlier period can be credited to the increasing incidence of chronic diseases, elevated funding from government and private entities, speedy growth in developing markets, growth in investments for cell and gene therapies, rise in healthcare spending, and increase in research and development expenditure in the pharmaceutical sector.

In the coming years, the market size for stem cell therapy is poised for swift expansion. By 2029, it is projected to reach a value of $14.6 billion, marking a compound annual growth rate (CAGR) of 12.1%. This growth during the forecast period is attributed to factors such as increased government backing, a rapidly aging population, heightened spending on research and development, and a greater expenditure on healthcare. Key trends anticipated for this period include keeping a close watch on progress in mesenchymal stem cell therapy in order to leverage field innovations, market-specific collaborations and acquisitions to foster product innovation and revenue growth, consideration towards investing in ipsc-derived nk cell development for patient treatment, the development of stem cell therapy, particularly for cancer treatment, by companies in the market to gain a competitive edge over somatic cell rivals; and the application of artificial intelligence by such firms to enhance product quality, safety and production efficiency.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

What External and Internal Drivers Are Contributing to the Growth of theStem Cell Therapy Market?

The increment in chronic diseases globally has played a significant role in boosting the stem cell therapy market. Increased working periods, inadequate physical exercise, and poor nutritional habits have led to a heightened incidence of these diseases, thus heightening the necessity for stem cell therapy. A United Nations article indicates that chronic diseases could account for 70% of worldwide deaths by 2030. The projected total burden of such chronic diseases would be around 60%. With the increasing occurrence of chronic diseases, the stem cell therapy market is likely to experience prominent growth.

What Segment Types Define the Stem Cell Therapy Market Structure?

The stem cell therapy market covered in this report is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others

4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:

1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells

2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3399&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Stem Cell Therapy Market?

North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Long-Term Trends Are Transforming the Competitive Landscape of the Stem Cell Therapy Market?

There is a growing trend of strategic collaborations amongst corporations in the stem cell therapy market. Such partnerships are mutually beneficial arrangements between two non-competing firms. For example, in May 2022, US-based SQZ Biotechnologies entered a strategic partnership with Canada-based STEMCELL Technologies Inc. They aim to design and market a research-use-only (RUO) microfluidic intracellular delivery system. This system, based on SQZ’s Cell Squeeze technology, will offer enhanced cell engineering capabilities to the life sciences sector for preclinical research. Both firms will unveil crucial findings regarding the system’s ability to effectively deliver cargoes to primary immune cell types, as well as advancements in cell engineering with mRNA and CRISPR/Cas9 in hematopoietic stem cells.

View the full report here:

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

What Is the Definition of the Stem Cell Therapy Market?

Stem cell therapy refers to a form of regenerative medicine that uses stem cells or their byproducts to stimulate the body’s natural repair process in damaged, malfunctioning, or wounded tissue. It is the next step in the transplantation of organs, replacing donor organs—which are scarce—with cells.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3399

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theStem Cell Therapy Market?

The escalating incidence of chronic illnesses has been a driving force behind the expansion of the stem cell therapy market. Factors like extended work hours, lack of physical movement, and poor dietary choices facilitate the spread of such diseases, thereby bolstering the demand for stem cell therapy. As per a United Nations report, chronic conditions are projected to account for 70% of all deaths globally by 2030. Furthermore, chronic diseases are predicted to represent around 60% of the worldwide disease burden. The increasing incidence of these conditions is likely to propel the growth of the stem cell therapy market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

#What Long-Term Growth Rate is Expected for theStem Cell Therapy Market Between 2025 and 2034?

In recent times, the stem cell therapy market has seen significant expansion. It is projected to escalate from $7.86 billion in 2024 to $9.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.7%. The growth witnessed in the historic period can be credited to an uptick in cases of chronic illnesses, increased funding from government entities and private bodies, swift growth in burgeoning markets, expansion of investments in cell and gene therapies, a rise in healthcare spending, and an escalation in r&d expenses in the pharmaceutical industry.

The market size of stem cell therapy is projected to experience substantial growth in the upcoming years, escalating to $14.6 billion in 2029 with a compound annual growth rate (CAGR) of 12.1%. This projected growth during the forecast period can be linked to factors such as increased government backing, a swiftly growing aging population, an upsurge in research and development expenditure, and a rise in healthcare spending. Key trends in the forecast period encompass focusing on closely tracking developments in mesenchymal stem cells therapy in order to capitalize on field advancements, market operators should partner and acquire other businesses to bolster product innovation and revenue, firms should contemplate investing in the development of ipsc-derived nk cells for patient treatment, companies in the stem cell therapy market ought to strive for advancements in stem cell therapy specifically for cancer to obtain a competitive edge against somatic cell competitors, and companies in the stem cell therapy market should leverage artificial intelligence to amplify product quality, safety, and manufacturing productivity.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3399

What Key Market Trends and Innovations Are Shaping the Future of theStem Cell Therapy Industry?

The stem cell therapy market is witnessing a growing trend of strategic partnerships among its companies. These collaborations, which are mutually advantageous contracts between two non-competitive companies, are being increasingly invested in by these firms. Take, for example, the May 2022 collaboration between SQZ Biotechnologies, a biotech firm from the United States, and STEMCELL Technologies Inc., a Canadian biotech firm. Their joint venture aims to develop and commercialise a research-use-only (RUO) microfluidic intracellular delivery system based on Cell Squeeze technology by SQZ to enhance cell engineering for preclinical research within the life science community. This project will enable both firms to reveal significant data regarding the RUO system’s ability to effectively deliver cargoes to primary immune cell types and demonstrate improvement in cell engineering using mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Which Companies Are Leading the Charge in Expanding theStem Cell Therapy Market Growth?

Major companies operating in the stem cell therapy market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mabion, Pure Biologics, Oncoarendi Therapeutics, Celon Pharma, Becton Dickinson And Company, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi S.A.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

How is the Global Stem Cell Therapy Market Segemented?

The stem cell therapy market covered in this report is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others

4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:

1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells

2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3399&type=smp

Which Geographics are Influencing the Growth of the Stem Cell Therapy Market?

North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Stem Cell Therapy Market 2025, By The Business Research Company:

Wires And Cables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/wires-and-cables-global-market-report

Electrical Steel Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electrical-steel-global-market-report

Iron And Steel Mills And Ferroalloy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/iron-and-steel-mills-and-ferroalloy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the stem cell therapy market grown over the years?

The market for stem cell therapy has been expanding swiftly in the past few years. The expected expansion is from $7.86 billion in 2024 to reach $9.26 billion in 2025, giving it a compound annual growth rate (CAGR) of 17.7%. Factors contributing to the historical growth of this market include an increased rate of chronic illnesses, greater financial support from government and private entities, the fast-paced development of emerging markets, more investments made in cell and gene therapies, a rise in healthcare spending, and an upward trend in pharmaceutical research and development expenditure.

What Is the forecasted market size and growth rate for the stem cell therapy market?

The market size for orthopedic devices is projected to experience significant expansion in the coming years, escalating to $67.05 billion by 2029 with a 5.0% compound annual growth rate (CAGR). This predicted growth in the forecast period can be ascribed to the rise in value-based healthcare models, emphasis on sustainability, innovative strategies for joint preservation, and improved implant coatings and materials. Key trends that are expected to arise during the forecast period include intelligent orthopedic devices, the use of robotics in orthopedic surgeries, personalized orthopedic braces, the application of nanotechnology in orthopedics, and the incorporation of telemedicine in orthopedic care.

Get your stem cell therapy market report here!

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

What are the major factors driving growth in the stem cell therapy market?

The escalation in the occurrence of chronic illnesses is leading to the expansion of the stem cell therapy market. Factors such as extended working hours, little physical exercise, and poor dietary choices are responsible for the heightened incidence of chronic diseases in individuals, therefore amplifying the demand for stem cell therapy. A United Nations article anticipates that by 2030, chronic diseases will be responsible for 70% of global deaths. Likewise, the global impact of chronic diseases is predicted to be around 60%. The increasing occurrence of chronic illnesses is anticipated to propel the growth of the stem cell therapy market.

What key areas define the segmentation of the global stem cell therapy Market?

The stem cell therapy market covered in this report is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others

4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:

1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells

2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

What are the top market players propelling the growth of the stem cell therapy industry?

Major companies operating in the stem cell therapy market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mabion, Pure Biologics, Oncoarendi Therapeutics, Celon Pharma, Becton Dickinson And Company, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi S.A.

What are the key trends shaping the future of the stem cell therapy market?

In the stem cell therapy market, the trend of companies entering into strategic collaborations is gaining traction. These partnerships, which are advantageous for both parties and involve entities that are not direct competitors, are on the rise. A case in point, SQZ Biotechnologies, a biotech firm from the US, collaborated with STEMCELL Technologies Inc., a Canadian biotech establishment in May 2022. Their project involves the creation and commercialization of a microfluidic intracellular delivery system for research purposes, based on SQZ’s Cell Squeeze technology. This would offer superior cell engineering assets to the life sciences sector for preliminary research. Both entities will disclose notable discoveries on the efficiency of this system in transporting cargoes to primary immune cell types. They will also illustrate advances in cell engineering employing mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3399

What regions are dominating the stem cell therapy market growth?

North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

3D Cell Culture Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Flow Cytometry Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR Will the Stem Cell Therapy Market Achieve During 2025–2034, and What Does It Indicate?

In recent years, the stem cell therapy market has seen significant growth. The market size, which was valued at $7.86 billion in 2024, is projected to inflate to $9.26 billion in 2025, with a compound annual growth rate (CAGR) of 17.7%. This upward trajectory during the historical period is due to several factors including a growing number of chronic diseases, increased funding from private and governmental bodies, a swift rise in developing markets, elevated investment into cell and gene therapies, a spike in healthcare spending, and an inflated expenditure on pharmaceutical research and development.

The market for stem cell therapy is anticipated to experience a swift expansion in the upcoming years, reaching a value of $14.6 billion in 2029, with a compound annual growth rate of 12.1%. This projected growth during the forecast period could result from factors such as enhanced government backing, swift rise in the elderly populace, escalating spendings on research and development, and increased expenditures on healthcare. Key trends for the upcoming period feature a focus on carefully examining advancements in mesenchymal stem cell therapy to leverage innovative leaps in the sector. Market players ought to engage in collaborations and acquisitions to promote product innovation and boost revenues, and consider investing in the development of ipsc-derived NK cells for patient treatment. To gain a competitive edge over somatic cell rivals, companies within the stem cell therapy market should focus on developing stem cell-based treatments, particularly for cancer. Moreover, these companies should also explore the utilization of artificial intelligence to enhance the quality, safety, and efficiency of their manufacturing processes.

How Are the key drivers Contributing to the Expansion of the stem cell therapy Market?

The escalating occurrence of long-term health conditions has led to the expansion of the stem cell therapy market. Factors such as extended hours of work, limited physical workout, and unhealthy dietary and drinking habits have led to an increase in the occurrence of these chronic health conditions among the population, thereby fueling the need for stem cell therapy. Based on an article by the United Nations, chronic diseases are predicted to account for 70% of total global deaths by 2030. The worldwide impact of these chronic health conditions will likely hit approximately 60%. With the increasing occurrence of these chronic health conditions, the demand for stem cell therapy which in turn propels its market growth.

Get Your Free Sample of the Global Stem Cell Therapy Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

Who Are the Key Firms Paving the Way for Growth in the Stem Cell Therapy Market?

Major companies operating in the stem cell therapy market include:

• Fujifilm Holding Corporation_x000D_

• Thermo Fisher Scientific Inc._x000D_

• Takara Bio Inc._x000D_

• MEDIPOST Co._x000D_

• Ltd._x000D_

What Are the Most Influential Trends Currently Shaping the Stem Cell Therapy Market?

Firms partaking in the stem cell therapy market are showing a growing trend towards strategic alliances. These strategic partnerships are a form of cooperative agreement between two entities which don’t have a direct competition, offering mutual benefits. To illustrate, SQZ Biotechnologies, an American biotechnology firm, entered into a partnership in May 2022 with STEMCELL Technologies Inc., a biotech firm based in Canada. The collaboration seeks to develop and bring to market a research-only microfluidic intracellular delivery system that exploits SQZ’s Cell Squeeze technology. This provides the life science fraternity with improved cell engineering capabilities intended for preclinical research. Both participating companies will share key discoveries regarding the potential of the research-only system for effectively conveying cargoes to primary immune cell types, showcasing advancements in cell engineering employing mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Get Instant Access to the Global Stem Cell Therapy Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Which Segments of the Stem Cell Therapy Market Hold the Most Potential for Future Development?

The stem cell therapy market covered in this report is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others

4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:

1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells

2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

Which Regions Are Essential for the Growth of the Stem Cell Therapy Market?

North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Elements Shape the Definition of the Stem Cell Therapy Market?

Stem cell therapy refers to a form of regenerative medicine that uses stem cells or their byproducts to stimulate the body’s natural repair process in damaged, malfunctioning, or wounded tissue. It is the next step in the transplantation of organs, replacing donor organs—which are scarce—with cells.

Browse Through More Similar Reports By The Business Research Company:

3D Cell Culture Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Flow Cytometry Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: